EHA

New EHA data reveal how badly Gilead's $4.9B bet on CD47 imploded
Fierce Biotech
Sun, 06/16/24 - 09:04 pm
Gilead Sciences
magrolimab
clinical trials
EHA
Kura files $100m offer after menin inhibitor results in AML
Pharmaphorum
Wed, 06/14/23 - 10:25 am
Kura Oncology
ziftomenib
AML
stock offering
EHA
EHA 2023 – Astrazeneca keeps up its complement defense
EP Vantage
Fri, 06/9/23 - 10:01 am
EHA
AstraZeneca
Alexion
Soliris
Ultomiris
Novartis
iptacopan
PNH
EHA: Survival data sets Daiichi Sankyo’s quizartinib back on track
Pharmaforum
Mon, 06/13/22 - 10:44 am
Daiichi Sankyo
EHA
quizartinib
clinical trials
acute myeloid leukemia
Cogent Soars on Positive Mid-Stage Data in Rare Blood Disorder
BioSpace
Sun, 06/12/22 - 08:23 pm
EHA
Cogent Biosciences
clinical trials
bezuclastinib
AdvSM
The hangover: Caribou's allogeneic CAR-T hit by durability doubts as half of patients relapse
Fierce Biotech
Fri, 06/10/22 - 10:55 am
Caribou Biosciences
CRISPR
CAR-T
allogenic CAR-T
EHA
non-Hodgkin's lymphoma
EHA 2022 preview – some good news at last
EP Vantage
Mon, 05/16/22 - 10:14 am
EHA
Caribou Biosciences
CB-010
Gracell
Autolus
Roche
Curocell
ADC Therapeutics
Mustang Bio
CRISPR Therapeutics’ CAR-T for Lymphoma Shows Early Promise
BioSpace
Thu, 05/12/22 - 10:42 pm
CRISPR Therapeutics
CTX130
clinical trials
lymphoma
EHA
EHA: Epizyme's first-in-class multiple myeloma drug candidate inhibits tumors in mice
Fierce Biotech
Mon, 06/14/21 - 10:41 am
EHA
Epizyme
Multiple Myeloma
EPZ-719
EHA: Johnson & Johnson, nearing Sanofi showdown, bolsters Darzalex's myeloma lead with 'unprecedented' survival data
Fierce Pharma
Mon, 06/14/21 - 10:27 am
JNJ
Darzalex
Multiple Myeloma
Sanofi
Sarclisa
EHA
EHA21: Novartis trumpets iptacopan as oral alternative to antibodies in PNH
Pharmaforum
Sat, 06/12/21 - 10:26 pm
Novartis
iptacopan
clinical trials
PNH
EHA
EHA 2021 – Curis’s renaissance continues
EP Vantage
Fri, 05/14/21 - 10:43 am
Curis
CA-4948
EHA
myelodysplastic syndrome
acute myelogenous leukemia
clinical trials
With Sanofi entering the multiple myeloma market, J&J flashes data on new rare disease
Endpoints
Mon, 06/15/20 - 10:51 am
EHA
JNJ
clinical trials
Darzalex
AL amyloidosis
EHA: AbbVie, Roche cement Venclexta's place in AML with survival win
Fierce Pharma
Sat, 06/13/20 - 11:32 pm
AbbVie
Roche
Venclexta
AML
EHA
EHA: Johnson & Johnson's Darzalex branches out beyond myeloma with AL amyloidosis win
Fierce Pharma
Sat, 06/13/20 - 11:31 pm
light chain amyloidosis
JNJ
Darzalex
EHA
New CRISPR, gene therapy results strengthen potential for treatment of blood diseases
BioPharma Dive
Fri, 06/12/20 - 11:11 am
CRISPR
gene therapy
beta thalassemia
sickle cell disease
CRISPR Therapeutics
Vertex
Bluebird Bio
EHA
Cancer drugmaker Agios offers promising data from two studies testing blood disorder drug
Endpoints
Fri, 06/12/20 - 10:58 am
EHA
Agios
mitapivat
thalassemia
EHA 2020 – Bluebird’s sickle cell plan takes shape, with a stark reminder
EP Vantage
Fri, 06/12/20 - 10:41 am
Bluebird Bio
sickle cell disease
LentiGlobin
EHA
Imago BioSciences Advances Myelofibrosis Trials, With Phase IIb Prelim Readout Imminent
BioSpace
Wed, 06/3/20 - 11:30 pm
Imago
clinical trials
EHA
myelofibrosis
bomedemstat
EHA 2019 – turnaround puts Arqule in the takeover frame
EP Vantage
Sat, 06/15/19 - 05:47 pm
Arqule
ARQ 531
EHA
Btk inhibitors